Found: 27
Select item for more details and to access through your institution.
Significance of the autoantibody assay in predicting the development of immune‐related adverse events in patients receiving atezolizumab plus bevacizumab combination therapy for unresectable hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2024, v. 54, n. 2, p. 162, doi. 10.1111/hepr.13969
- By:
- Publication type:
- Article
Significance of serum IP‐10/CXCL10 measurement in predicting post‐direct acting antiviral treatment liver function in patients with HCV‐decompensated liver cirrhosis.
- Published in:
- Hepatology Research, 2023, v. 53, n. 4, p. 280, doi. 10.1111/hepr.13861
- By:
- Publication type:
- Article
Early diagnosis of hepatic inflammation in Japanese nonalcoholic fatty liver disease patients using 3D MR elastography.
- Published in:
- Hepatology Research, 2023, v. 53, n. 3, p. 208, doi. 10.1111/hepr.13858
- By:
- Publication type:
- Article
Deep sequencing analysis of serum hepatitis B virus‐RNA during nucleot(s)ide analogue therapy.
- Published in:
- Hepatology Research, 2021, v. 51, n. 1, p. 39, doi. 10.1111/hepr.13574
- By:
- Publication type:
- Article
Cancer‐related genetic changes in multistep hepatocarcinogenesis and their correlation with imaging and histological findings.
- Published in:
- Hepatology Research, 2020, v. 50, n. 9, p. 1071, doi. 10.1111/hepr.13529
- By:
- Publication type:
- Article
The Impact of Antiviral Therapy for Hepatitis C Virus on the Survival of Patients after Hepatocellular Carcinoma Treatment.
- Published in:
- Internal Medicine, 2022, v. 61, n. 18, p. 2721, doi. 10.2169/internalmedicine.8456-21
- By:
- Publication type:
- Article
Hepatitis B virus (HBV)‐infected patients with low hepatitis B surface antigen and high hepatitis B core‐related antigen titers have a high risk of HBV‐related hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2019, v. 49, n. 1, p. 51, doi. 10.1111/hepr.13277
- By:
- Publication type:
- Article
Liver stiffness measurement for risk assessment of hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2015, v. 45, n. 5, p. 523, doi. 10.1111/hepr.12377
- By:
- Publication type:
- Article
Deep sequencing analysis of variants resistant to the non-structural 5 A inhibitor daclatasvir in patients with genotype 1b hepatitis C virus infection.
- Published in:
- Hepatology Research, 2014, v. 44, n. 14, p. E360, doi. 10.1111/hepr.12316
- By:
- Publication type:
- Article
Hepatocellular carcinoma risk assessment using gadoxetic acid-enhanced hepatocyte phase magnetic resonance imaging.
- Published in:
- Hepatology Research, 2014, v. 44, n. 13, p. 1339, doi. 10.1111/hepr.12309
- By:
- Publication type:
- Article
Changes in hepatitis C viral load during first 14 days can predict the undetectable time point of serum viral load by pegylated interferon and ribavirin therapy.
- Published in:
- Hepatology Research, 2011, v. 41, n. 3, p. 217, doi. 10.1111/j.1872-034X.2010.00768.x
- By:
- Publication type:
- Article
Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage and response to interferon therapy.
- Published in:
- Hepatology Research, 2010, v. 40, n. 9, p. 870, doi. 10.1111/j.1872-034X.2010.00692.x
- By:
- Publication type:
- Article
A predictive model of response to peginterferon ribavirin in chronic hepatitis C using classification and regression tree analysis.
- Published in:
- Hepatology Research, 2010, v. 40, n. 3, p. 251, doi. 10.1111/j.1872-034X.2009.00607.x
- By:
- Publication type:
- Article
Relationship between Plasma IP-10/CXCL10 Levels and the Initial Therapeutic Response in Patients Treated with Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma.
- Published in:
- Oncology, 2023, v. 101, n. 10, p. 655, doi. 10.1159/000531689
- By:
- Publication type:
- Article
Impact of Renal Function on the Prognosis of Patients Receiving Atezolizumab/Bevacizumab Combination Therapy and Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma.
- Published in:
- Oncology, 2023, v. 101, n. 10, p. 609, doi. 10.1159/000531111
- By:
- Publication type:
- Article
Prediction of Therapeutic Response Using Contrast-Enhanced Ultrasound in Japanese Patients Treated with Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma.
- Published in:
- Oncology, 2023, v. 101, n. 3, p. 173, doi. 10.1159/000527752
- By:
- Publication type:
- Article
A Simple Clinical Scoring System to Determine the Risk of Pancreatic Cancer in the General Population.
- Published in:
- Diagnostics (2075-4418), 2024, v. 14, n. 6, p. 651, doi. 10.3390/diagnostics14060651
- By:
- Publication type:
- Article
Kuhlia boninensis (Fowler, 1907), a junior synonym of Kuhlia munda (De Vis, 1884) (Perciformes: Kuhliidae).
- Published in:
- Ichthyological Research, 2004, v. 51, n. 1, p. 70, doi. 10.1007/s10228-003-0185-3
- By:
- Publication type:
- Article
Spontaneous portosystemic shunt diameter predicts liver function after balloon‐occluded retrograde transvenous obliteration.
- Published in:
- JGH Open, 2022, v. 6, n. 2, p. 139, doi. 10.1002/jgh3.12712
- By:
- Publication type:
- Article
Effect of a combination of pemafibrate and a mild low‐carbohydrate diet on obese and non‐obese patients with metabolic‐associated fatty liver disease.
- Published in:
- Journal of Gastroenterology & Hepatology, 2023, v. 38, n. 6, p. 921, doi. 10.1111/jgh.16154
- By:
- Publication type:
- Article
Usefulness of Body Position Change during Local Ablation Therapies for the High-Risk Location Hepatocellular Carcinoma.
- Published in:
- Cancers, 2024, v. 16, n. 5, p. 1036, doi. 10.3390/cancers16051036
- By:
- Publication type:
- Article
HBV preS deletion mapping using deep sequencing demonstrates a unique association with viral markers.
- Published in:
- PLoS ONE, 2019, v. 14, n. 2, p. 1, doi. 10.1371/journal.pone.0212559
- By:
- Publication type:
- Article
Semiannual Imaging Surveillance Is Associated with Better Survival in Patients with Non-B, Non-C Hepatocellular Carcinoma.
- Published in:
- Mediators of Inflammation, 2015, v. 2015, p. 1, doi. 10.1155/2015/687484
- By:
- Publication type:
- Article
Association between alanine aminotransferase elevation and UGT1A1*6 polymorphisms in daclatasvir and asunaprevir combination therapy for chronic hepatitis C.
- Published in:
- Journal of Gastroenterology, 2018, v. 53, n. 6, p. 780, doi. 10.1007/s00535-017-1405-3
- By:
- Publication type:
- Article
Association between alanine aminotransferase elevation and UGT1A1*6 polymorphisms in daclatasvir and asunaprevir combination therapy for chronic hepatitis C.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Novel Method of Calculating the Drained Liver Volume Using a 3D Volume Analyzer for Biliary Drainage of Unresectable Malignant Hilar Biliary Obstruction.
- Published in:
- Digestive Diseases & Sciences, 2024, v. 69, n. 3, p. 969, doi. 10.1007/s10620-024-08294-z
- By:
- Publication type:
- Article
Usefulness of Circulating CYFRA21-1 in Patients as a Biomarker in Patients Taking Sorafenib or Lenvatinib for Unresectable Hepatocellular Carcinoma.
- Published in:
- Reports (MDPI AG), 2021, v. 4, n. 3, p. 1, doi. 10.3390/reports4030025
- By:
- Publication type:
- Article